KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Current Assets: 2018-2025

Historic Current Assets for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $333.0 million.

  • Twist Bioscience's Current Assets fell 3.98% to $333.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $333.0 million, marking a year-over-year decrease of 3.98%. This contributed to the annual value of $333.0 million for FY2025, which is 3.98% down from last year.
  • Latest data reveals that Twist Bioscience reported Current Assets of $333.0 million as of Q3 2025, which was down 2.00% from $339.8 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Current Assets registered a high of $664.4 million during Q1 2022, and its lowest value of $333.0 million during Q3 2025.
  • In the last 3 years, Twist Bioscience's Current Assets had a median value of $361.8 million in 2024 and averaged $380.6 million.
  • Examining YoY changes over the last 5 years, Twist Bioscience's Current Assets showed a top increase of 133.66% in 2021 and a maximum decrease of 39.31% in 2021.
  • Twist Bioscience's Current Assets (Quarterly) stood at $385.0 million in 2021, then surged by 40.74% to $541.9 million in 2022, then dropped by 27.98% to $390.2 million in 2023, then decreased by 11.51% to $345.3 million in 2024, then declined by 3.98% to $333.0 million in 2025.
  • Its last three reported values are $333.0 million in Q3 2025, $339.8 million for Q2 2025, and $338.4 million during Q1 2025.